Nerve Repair and Regeneration Device Demand Driven by Rising Cases of Neurological Diseases

Re-publier cet article

<h1>Nerve Repair and Regeneration Device Demand Driven by Rising Cases of Neurological Diseases</h1><strong> Author: <a href='http://fr.articleseen.com/profile_Pramod Kumar.aspx'>Pramod Kumar</a></strong><br /><p>According to the World Health Organization (WHO), nearly 10 million new cases of dementia are recorded every year worldwide. Dementia is caused, due to several injuries and diseases that have a primary or secondary effect on the brain. As per the WHO, Alzheimer's disease is the most prevalent type of dementia and may account for 60–70% of cases. Further, the organization also estimates that epilepsy affects nearly 50 million people worldwide. Additionally, the Parkinson's Foundation states that over 10 million people worldwide are currently living with Parkinson's disease. This growth can also be ascribed to the booming global geriatric population, as they are extremely prone to chronic pain and neurologic diseases. According to the United Nations Population Fund (UNFPA), the global population of people aged 60 years and above will account for nearly 22% of the worldwide population by 2050. To cure patients suffering from neurological disorders and chronic pain, medical professionals are increasingly using neurostimulation and neuromodulation devices to generate new axons, glial cells, neurons, and myelin by using microelectrodes. Doctors implant these devices in the brain through surgeries to activate nerves in the nervous system. These devices help in generating paresthesia, which is a tingling sensation, at particular time intervals in the nervous system., which assists healthcare practitioners in treating neurological disorders and chronic pain. Nerve repair and regeneration devices used for such applications are manufactured by St. Jude Medical Inc., Orthomed S.A.S., Axogen Inc., Medtronic Plc, Stryker Corporation, Polyganics B.V., Integra Lifesciences Holdings Corporation, Baxter International Inc., Boston Scientific Corporation, and Cyberonics Inc. Among these, Medtronic Plc is the largest producer of neurostimulation and targeted drug delivery systems, such as Deep Brain Stimulation (DBS), Gastric Electrical Stimulation (GES), Spinal Cord Stimulation (SCS), and Sacral Nerve Stimulation (SNS) systems, which are used to manage common movement diseases, chronic pain, urologic and gastrointestinal disorders, and spasticity. Thus, the soaring cases of neurological diseases and the surging geriatric population will fuel the adoption of nerve repair and regeneration devices in the upcoming years. Access Detailed Report Nerve Repair and Regeneration Market Growth Factors, and Trends @ https://www.psmarketresearch.com/market-analysis/nerve-repair-and-regeneration-market </p><strong>About the Author:</strong><br />Pramod has around 7 years of experience in market research and consulting services for healthcare industry. He holds varied experience in market sizing and forecasting with varied models, competition landscape, consumer behavior analysis, opportunity analysis, product/company benchmarking, data mining and others. <p> Article Source: <a href='http://fr.articleseen.com/Article_Nerve-Repair-and-Regeneration-Device-Demand-Driven-by-Rising-Cases-of-Neurological-Diseases_1118.aspx'> http://fr.articleseen.com/Article_Nerve Repair and Regeneration Device Demand Driven by Rising Cases of Neurological Diseases_1118.aspx</a></p>

Source de l'article : http://fr.articleseen.com/Article_Nerve Repair and Regeneration Device Demand Driven by Rising Cases of Neurological Diseases_1118.aspx

Mots-clés : https://www.psmarketresearch.com/market-analysis/nerve-repair-and-regeneration-market,

Catégorie : D'affaires : PR